STOCKWATCH
·
Healthcare Research- Analytics & Technology
Quarterly Result28 Jan 2026, 04:51 pm

Vimta Labs Reports Q3 & 9M FY26 Results: Total Income at Rs. 1,005 Mn in Q3, up 10.2% YoY

AI Summary

Vimta Labs Limited, a leading Contract Research and Testing Organisation, has announced its financial results for the quarter and nine months ended December 31, 2025. The company reported a total income of Rs. 1,005 Mn in Q3 FY26, reflecting a YoY growth of 10.2%. The EBITDA margins stood at 34.3% and the PAT margin was at 17.5%. The company's strategic direction remains confident and it will continue to invest in capabilities that enhance long-term value for clients, stakeholders, and the broader people wellness ecosystem.

Key Highlights

  • Total Income for Q3 FY26 was at Rs. 1,005 Mn
  • EBITDA for Q3 FY26 was Rs. 344 Mn with a margin of 34.3%
  • PAT for Q3 FY26 was Rs. 176 Mn with a margin of 17.5%
  • Total Income for 9M FY26 was at Rs. 3,043 Mn
  • EBITDA for 9M FY26 was Rs. 1,068 Mn with a margin of 35.1%
  • PAT for 9M FY26 was Rs. 564 Mn with a margin of 18.5%
VIMTALABS
Healthcare Research- Analytics & Technology
VIMTA LABS LTD.-$

Price Impact